The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 May 27

PMID 37240069

Authors

Stanislav Kotlyarov

Affiliations

Soon will be listed here.

Abstract

Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and atherosclerotic cardiovascular disease (ASCVD). These diseases share common pathogenesis and significantly influence each other's clinical presentation and prognosis. There is increasing evidence that the mechanisms underlying the comorbidity of COPD and ASCVD are complex and multifactorial. Smoking-induced systemic inflammation, impaired endothelial function and oxidative stress may contribute to the development and progression of both diseases. The components present in tobacco smoke can have adverse effects on various cellular functions, including macrophages and endothelial cells. Smoking may also affect the innate immune system, impair apoptosis, and promote oxidative stress in the respiratory and vascular systems. The purpose of this review is to discuss the importance of smoking in the mechanisms underlying the comorbid course of COPD and ASCVD.

Citing Articles

Investigating the role of eight SNPs in for COPD susceptibility in the Chinese elderly population.

Zheng Y, Zhao J, Liu M, Liu Y, Ding Y, Xie T Ann Med. 2025; 57(1):2474726.

PMID: 40072291 PMC: 11905312. DOI: 10.1080/07853890.2025.2474726.

Assessment of the right ventricular strain, left ventricular strain and left atrial strain using speckle tracking echocardiography in patients with chronic obstructive pulmonary disease.

Nguyen Ngoc Dang H, Viet Luong T, Thi Y Nguyen N, Khanh Tran H, Thi Nguyen Tran H, Minh Vu H BMJ Open Respir Res. 2025; 12(1).

PMID: 40050037 PMC: 11887318. DOI: 10.1136/bmjresp-2024-002706.

Cigarette Smoking Patterns Among Racial and Ethnic Groups With Chronic Lung Diseases During the COVID-19 Pandemic.

Seegulam V, Washington C, Surendran P, Falise A, Gomez-Manjarres D, Lopez-Quintero C AJPM Focus. 2025; 4(3):100310.

PMID: 39963202 PMC: 11830302. DOI: 10.1016/j.focus.2024.100310.

miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis.

Mirra D, Esposito R, Spaziano G, Rafaniello C, Panico F, Squillante A Int J Mol Sci. 2025; 26(3).

PMID: 39941045 PMC: 11818525. DOI: 10.3390/ijms26031277.

The Role of Trace Elements in COPD: Pathogenetic Mechanisms and Therapeutic Potential of Zinc, Iron, Magnesium, Selenium, Manganese, Copper, and Calcium.

Fekete M, Lehoczki A, Csipo T, Fazekas-Pongor V, Szappanos A, Major D Nutrients. 2024; 16(23).

PMID: 39683514 PMC: 11644833. DOI: 10.3390/nu16234118.

References

Pelegrin P, Surprenant A . Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem. 2006; 282(4):2386-94. DOI: 10.1074/jbc.M610351200. View

Giunzioni I, Bonomo A, Bishop E, Castiglioni S, Corsini A, Bellosta S . Cigarette smoke condensate affects monocyte interaction with endothelium. Atherosclerosis. 2014; 234(2):383-90. DOI: 10.1016/j.atherosclerosis.2014.03.029. View

Warboys C, Amini N, De Luca A, Evans P . The role of blood flow in determining the sites of atherosclerotic plaques. F1000 Med Rep. 2011; 3:5. PMC: 3096883. DOI: 10.3410/M3-5. View

Sonett J, Goldklang M, Sklepkiewicz P, Gerber A, Trischler J, Zelonina T . A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure. FASEB J. 2018; :fj201701381. PMC: 6219826. DOI: 10.1096/fj.201701381. View

Shirahata T, Sato H, Yogi S, Inoue K, Niitsu M, Miyazawa H . Possible association of high-density lipoprotein cholesterol levels with trunk muscle deficits and decrease in energy expenditure in patients with or at risk for COPD: A pilot study. Respir Investig. 2022; 60(5):720-724. DOI: 10.1016/j.resinv.2022.06.005. View

Tertov V, Orekhov A, Kacharava A, Sobenin I, Perova N, Smirnov V . Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp Mol Pathol. 1990; 52(3):300-8. DOI: 10.1016/0014-4800(90)90071-k. View

Santos S, Peinado V, Ramirez J, Morales-Blanhir J, Bastos R, Roca J . Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167(9):1250-6. DOI: 10.1164/rccm.200210-1233OC. View

Atkins G, Jain M . Role of Krüppel-like transcription factors in endothelial biology. Circ Res. 2007; 100(12):1686-95. DOI: 10.1161/01.RES.0000267856.00713.0a. View

Keatings V, Collins P, Scott D, Barnes P . Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996; 153(2):530-4. DOI: 10.1164/ajrccm.153.2.8564092. View

10.

Stein J, Fenigstein H . Pathological anatomy of hunger disease. Curr Concepts Nutr. 1979; 7:207-34. View

11.

Criner G, Connett J, Aaron S, Albert R, Bailey W, Casaburi R . Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med. 2014; 370(23):2201-10. PMC: 4375247. DOI: 10.1056/NEJMoa1403086. View

12.

Zou M, Ullrich V . Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 1996; 382(1-2):101-4. DOI: 10.1016/0014-5793(96)00160-3. View

13.

Davis B, Zeki A, Bratt J, Wang L, Filosto S, Walby W . Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur Respir J. 2012; 42(2):350-61. PMC: 6082623. DOI: 10.1183/09031936.00042512. View

14.

Martey C, Pollock S, Turner C, OReilly K, Baglole C, Phipps R . Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol. 2004; 287(5):L981-91. DOI: 10.1152/ajplung.00239.2003. View

15.

Nachmias N, Langier S, Brzezinski R, Siterman M, Stark M, Etkin S . NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. PLoS One. 2019; 14(5):e0214622. PMC: 6529002. DOI: 10.1371/journal.pone.0214622. View

16.

Kotlyarov S . Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease. Int J Mol Sci. 2022; 23(9). PMC: 9099629. DOI: 10.3390/ijms23094768. View

17.

Geraghty P, Dabo A, DArmiento J . TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem. 2011; 286(34):30211-8. PMC: 3191060. DOI: 10.1074/jbc.M111.238824. View

18.

Rurik J, Aghajanian H, Epstein J . Immune Cells and Immunotherapy for Cardiac Injury and Repair. Circ Res. 2021; 128(11):1766-1779. PMC: 8171813. DOI: 10.1161/CIRCRESAHA.121.318005. View

19.

Leem A, Kim Y, Chung K, Park M, Kang Y, Park Y . Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity. Respir Res. 2022; 23(1):185. PMC: 9281034. DOI: 10.1186/s12931-022-02109-3. View

20.

LIEBOW A . Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis. 1959; 80(1, Part 2):67-93. DOI: 10.1164/arrd.1959.80.1P2.67. View